Redsense Medical AB (publ) (XSAT:REDS)
Sweden
· Delayed Price · Currency is SEK 2.950
+0.020 (0.68%)
At close: Apr 28, 2026
Redsense Medical AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 | Upgrade
|
| Depreciation & Amortization | 0.07 | 0.07 | 0.06 | 0.05 | 0.03 | Upgrade
|
| Other Amortization | 0.56 | - | - | - | 0.15 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.02 | - | - | - | - | Upgrade
|
| Other Operating Activities | 1.85 | -1.08 | -1.58 | -0.08 | -2.29 | Upgrade
|
| Change in Accounts Receivable | -0.57 | -1.73 | 0.98 | -1.29 | -1.08 | Upgrade
|
| Change in Inventory | -2.72 | -4.63 | 0.18 | -0.1 | 0.91 | Upgrade
|
| Change in Other Net Operating Assets | 2.76 | -1.2 | -0.17 | 0.4 | -1.97 | Upgrade
|
| Operating Cash Flow | -5.2 | -8.23 | -5.05 | -9.78 | -12.22 | Upgrade
|
| Capital Expenditures | -0.03 | -0.02 | -0.05 | -0.05 | -0.36 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -2.78 | -0.59 | -0.55 | -2.41 | -8.86 | Upgrade
|
| Investment in Securities | - | - | 8.95 | 13.33 | -0.5 | Upgrade
|
| Other Investing Activities | - | - | - | - | -0 | Upgrade
|
| Investing Cash Flow | -2.8 | -0.61 | 8.35 | 10.87 | -9.71 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 2.57 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -2.57 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -2.57 | 2.57 | Upgrade
|
| Issuance of Common Stock | - | 17.23 | - | - | - | Upgrade
|
| Common Dividends Paid | - | - | - | - | -4.46 | Upgrade
|
| Other Financing Activities | - | - | - | 0.18 | - | Upgrade
|
| Financing Cash Flow | - | 17.23 | - | -2.4 | -1.89 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | -0.21 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | Upgrade
|
| Net Cash Flow | -8 | 8.39 | 3.29 | -1.31 | -24.02 | Upgrade
|
| Free Cash Flow | -5.23 | -8.25 | -5.1 | -9.83 | -12.58 | Upgrade
|
| Free Cash Flow Margin | -19.51% | -28.66% | -20.00% | -58.68% | -76.98% | Upgrade
|
| Free Cash Flow Per Share | -0.29 | -0.48 | -0.36 | -0.70 | -0.90 | Upgrade
|
| Levered Free Cash Flow | -5.02 | -9.22 | -2.73 | -9.9 | -19.17 | Upgrade
|
| Unlevered Free Cash Flow | -5 | -9.2 | -2.71 | -9.84 | -19.13 | Upgrade
|
| Change in Working Capital | -0.52 | -7.56 | 0.98 | -1 | -2.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.